The introduction of this product into the body, whether by ingestion, injection, or any other means, is strictly prohibited by law
RNA therapeutics for cancer therapy, while promising and innovative, are associated with several potential toxicities that may arise in patients due to the nature of the molecules, delivery systems, and their interactions with host biology
Our product range: 1
Typical supplementation doses in clinical trials range from 3 to 5 grams daily, often divided into multiple doses, with treatment durations of 4-12 weeks
An FDA panel with ties to the industry recommended loosening regulations on six peptides over objections from FDA scientists about a lack of data
Schwedhelm E, Tan-Andresen J, Maas R, Riederer U, Schulze F, et al